Literature DB >> 9363991

Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc(delta716) knockout mice.

K Hioki1, N Shivapurkar, H Oshima, O Alabaster, M Oshima, M M Taketo.   

Abstract

Most epidemiological and animal studies show a positive correlation of the dietary intake of fat with the incidence of colon cancer, whereas an inverse correlation of the dietary intake of fiber. In rats fed a diet low in fat and high in wheat bran fiber and calcium, a significant decrease was reported in the number of azoxymethane-induced aberrant crypt foci compared with those fed a high-fat, low-fiber and low-calcium diet. Mutations in the human APC gene play a key role, not only in familial adenomatous polyposis, but also in many sporadic cancers of the entire digestive tract. We previously constructed a mouse strain Apc(delta716), carrying a truncation mutation at codon 716 of the Apc gene, the homolog of human APC (10). The heterozygous mice developed numerous intestinal polyps, and all microadenomas dissected from the earliest polyps had already lost the wild-type allele, indicating the loss of heterozygosity. Using these Apc(delta716) knockout mice, we have investigated the effect of a low-fat and high-fiber diet (LRD for 'low-risk' diet) on intestinal polyposis, and compared it with that of a high-fat and low-fiber diet (HRD for 'high-risk' diet). The mice were fed either diet for 7 weeks, and the number and size of intestinal polyps were scored. The LRD-fed mice had fewer polyps than the HRD-fed mice, by 36% in the small intestine and by 64% in the colon. As for the polyp size distribution, there was no significant difference between the HRD- and LRD-fed mice. These results indicate that LRD can suppress intestinal polyposis compared with HRD which does not, and suggest that its suppression is at the initiation of polyp formation. This is likely to be due to a decreased frequency of loss of heterozygosity, rather than a retarded growth of the polyp adenomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9363991     DOI: 10.1093/carcin/18.10.1863

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli.

Authors:  C Soravia; T Berk; L Madlensky; A Mitri; H Cheng; S Gallinger; Z Cohen; B Bapat
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

2.  Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells.

Authors:  C Domon-Dell; Q Wang; S Kim; M Kedinger; B M Evers; J-N Freund
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 3.  Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.

Authors:  Deacqunita L Diggs; Ashley C Huderson; Kelly L Harris; Jeremy N Myers; Leah D Banks; Perumalla V Rekhadevi; Mohammad S Niaz; Aramandla Ramesh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2011-10       Impact factor: 3.781

Review 4.  Mouse models for unraveling the importance of diet in colon cancer prevention.

Authors:  Alexandra E Tammariello; John A Milner
Journal:  J Nutr Biochem       Date:  2010-02       Impact factor: 6.048

Review 5.  Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system.

Authors:  Denis E Corpet; Fabrice Pierre
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-05       Impact factor: 4.254

6.  Surveillance and Treatment of Periampullary and Duodenal Adenomas in Familial Adenomatous Polyposis.

Authors:  J. Chad Johnson; James A. DiSario; William M. Grady
Journal:  Curr Treat Options Gastroenterol       Date:  2004-04

7.  Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis.

Authors:  R D Verschoyle; P Greaves; H Cai; R E Edwards; W P Steward; A J Gescher
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.